Delivery Order SPE2DR25D2006-SPE2DR26F55ZA
- Not listed
- The Defense Logistics Agency awarded a $1,485.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IYUZEH 0.005% eye drop (5 units) on October 22, 2025, with completion scheduled for October 23, 2025. This competitively awarded contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded a $1,577.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for IYUZEH 0.005% eye drops on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-competitive delivery order will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The contract represents a small-value transaction typical of routine pharmaceutical procurement through the federal medical supply chain supporting...
- The Defense Logistics Agency awarded a delivery order valued at $3,011.01 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of IYUZEH 0.005% eye drops. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $6,758.72 to AmerisourceBergen Drug Corp for IYUZEH 0.005% eye drops. This competitively awarded contract, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a pediatric pharmaceutical supply supporting federal medical procurement needs. The delivery order was fulfilled from AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,222.87 to AmerisourceBergen Drug Corp for the supply of IYUZEH 0.005% eye drop medication. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract, valued at $1,158.74, is for the supply of IYUZEH 0.005% eye drops. The contract is a firm fixed-price, non-set-aside award with a performance period through June 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,885.79, is a delivery order for the supply of "IYUZEH 0.005% EYE DROP 5S" medical products. The contract is a firm fixed-price agreement with a completion date of March 31, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,011.60 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3 mL units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,571.97 delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F55ZADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,528.26 to AmerisourceBergen Drug Corp for IYUZEH 0.005% Eye Drop (5S) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of pharmaceutical procurement activities supporting federal medical supply chains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems and other federal customers worldwide. The company's portfolio encompasses brand-name and generic pharmaceuticals across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/7/25 |